… Antiangiogenic therapy has become the most important treatment modality for patients with
advanced … levels of alpha-fetoprotein (AFP) as a potential biomarker for treatment efficacy of …

… of treatment response. In this review, the evidence regarding the prognostic value of serum
α-fetoprotein and the value of serial α-fetoprotein in the monitoring of treatment efficacy will …

… surrogate efficacy measure for new cancer treatments. However, in patients treated with …
We investigated the prognostic usefulness of a decrease in serum alpha-fetoprotein (AFP) …

… between changes in AFP during treatment and outcomes of efficacy measures in the pooled
population of patients with AFP ≥ 400 ng/ml, in both the REACH-2 and REACH studies. …

… alpha-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) levels in patients with advanced
hepatocellular carcinoma (HCC) treated … tumor markers and treatment efficacy. Methods: …

… patients who underwent ICI treatment. The patients were divided into high and low groups
based on the AFP threshold of 20 ng/ml. The efficacy of ICI treatment was assessed using …

… as an effective tool to assess treatment efficacy and predict tumor … with data on treatment
efficacy monitoring and planning for … As shown in Table 2, we assessed the treatment efficacy in …

… On the other hand, hAFP plus methotrexate can be used for treatment of cancer, where … of
efficacy in reducing clinical score of disease activity and increasing muscle strength in treated …

… Clinicians face difficulty in predicting the efficacy of hepatocellular carcinoma (HCC) 77
treatments as there is no optimal surrogate endpoint for overall survival. Further, 78 …

Background: Post-treatment alpha-fetoprotein (AFP) response has been reported to be
associated with prognosis of hepatocellular carcinoma (HCC) patients, but the results were not …